Michael Alexanian is studying two promising genetic avenues for addressing heart failure, a massive global health burden in need of innovative treatments.

Ayush Midha, a graduate student in the Jain Lab, studies how the body's metabolism adapts to low oxygen—work that's uncovered backup energy pathways, potential fertility treatments, and a link between...

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily targets the respiratory epithelium, yet severe disease features diffuse lung injury and hyperinflammatory syndromes driven by dys...

A new discovery reveals how a SARS-CoV-2 protein reprograms immune cells to accelerate viral spread--and points to a new strategy for therapeutic intervention.

The fellowship provides three years of funding for graduate students pursuing groundbreaking immunology research.

Scientists are getting a step closer to understanding exactly how autism develops in the brain – and what might work to treat it.

After more than a decade, UCSF scientists have mapped around 100 varied genes associated with profound autism to a smaller set of biological pathways, offering a promising path for developing drugs.

Gladstone Audio News · Episode

Gladstone scientists are developing new AI tools that promise to revolutionize how science is done and lead to new treatments for the most devastating diseases.

In this video, Gladstone scientists Emma Dann and Ronghui Zhu explain how their new study offers a powerful framework for designing cancer immunotherapies and treating autoimmune conditions.

A gene therapy could restore heart function in over 25% of children born with mutations that cause cardiomyopathy.

YouTube video by Gladstone Institutes

YouTube video by Gladstone Institutes

An unprecedented map of 22 million immune cells provides the functional rulebook for virtual biology and next-generation immunotherapies.

Systematic mapping of protein-protein interaction (PPI) networks and determining how causal mutations rewire them in autism spectrum disorder (ASD) provide a powerful framework for uncovering disease ...

Michael Alexanian is studying two promising genetic avenues for addressing heart failure, a massive global health burden in need of innovative treatments.

The most credible voices in longevity are mostly not the most visible ones. Of the 100 people ranked in the Unfiltered Longevity 100 for 2026, 38 are working scientists whose standing rests on peer-reviewed output, institutional position and replication...

YouTube video by Gladstone Institutes

Twenty years after his Nobel-winning discovery, doctors are using Yamanaka's cell-reprogramming breakthrough to treat real patients—and address aging itself.

Meet Lexi Schneider, a PhD student using innovative technology to uncover how the blood-brain barrier communicates.

By studying a gene associated with congenital heart defects, scientists uncovered a mechanism showing how small reductions in protein levels can disrupt DNA's three-dimensional structure and lead to disease.

The Damon Runyon Cancer Research Foundation has named 14 new Damon Runyon Fellows, brilliant postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading s...

Engineered spinal interneurons grown from human stem cells survived inside injured rats, took input from the brainstem and passed signals on to the diaphragm, though every animal needed daily immunosu...

Meet the FY2025-2026 CRI Irvington and Immuno-Informatics Postdoctoral Fellows, the next generation of scientists helping push the field of cancer immunotherapy forward.

It is 20 years since induced pluripotent stem cells shook biomedicine. Public trust must be retained now that clinical trials are well under way.

Scientists from across the NOMIS community gathered in Switzerland for the inaugural NOMIS Fellows Symposium.

YouTube video by Gladstone Institutes

It is 20 years since induced pluripotent stem cells shook biomedicine. Public trust must be retained now that clinical trials are well under way.

After he was diagnosed with “silent” epileptic seizures, doctors were able to treat his memory loss and confusion.

Primary human myeloid cells are efficiently edited using virus-like particles.

Secret science. Billionaire backers. Inside the wild quest to turn growing old into a thing of the past.

YouTube video by Gladstone Institutes

Gladstone and UCSF scientists developed a method to genetically edit myeloid cells, immune cells that act as the body's first responders.

Primary human myeloid cells are efficiently edited using virus-like particles.

The first mRNA flu vaccine is expected to arrive for the 2026-27 season, giving older adults another option alongside conventional flu shots.

An in vivo model that is able to recover human T cells from solid tumours can identify targets to help improve CAR T cell antitumour activity.